Last 2,590 KRW
Change Today -55.00 / -2.08%
Volume 20.8K
109820 On Other Exchanges
As of 1:06 AM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

genematrix inc (109820) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/17/14 - 5,340
52 Week Low
02/10/14 - 1,630
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GENEMATRIX INC (109820)

Related News

No related news articles were found.

genematrix inc (109820) Related Businessweek News

No Related Businessweek News Found

genematrix inc (109820) Details

GeneMatrix Inc., a biotech company, is engaged in the development of platform and molecular diagnostics products. It develops clinical diagnostic test panels and systems targeting the molecular diagnosis for drug reaction determination, and confirmed diagnosis and prognosis of infectious/genetic diseases comprising HBV, HIV and TB, and genetic syndromes, such as autism. The company is also involved in the research and development for the identification of gene makers that determine individual pathogenic sensitivity; and functional genomics for cardiovascular disease, autism, infectious diseases, forensic science, and clinical diagnostics. In addition, it is engaged in the development and commercialization of theranostic systems; involved in the research and development of convergence technology based molecular diagnostic platform for theranostics; and development of systems for microorganism diagnostics for clinical use and for food, agricultural, forest, and fisheries. The company is headquartered in Seongnam-si, South Korea.

genematrix inc (109820) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

genematrix inc (109820) Key Developments

GeneMatrix Inc., Annual General Meeting, Mar 28, 2014

GeneMatrix Inc., Annual General Meeting, Mar 28, 2014., at 11:00 Korea Standard Time. Location: Korea Bio Park B- 700 auditorium. Agenda: To consider the approval of financial statement; to consider the election of Director; to consider the approval of director remuneration; to consider the approval of the remuneration; and to consider other references concerning investment decisions.

GeneMatrix Inc., Annual General Meeting, Mar 29, 2013

GeneMatrix Inc., Annual General Meeting, Mar 29, 2013., at 09:00 Korea Standard Time. Location: B Bio Park Auditorium, Korea sampyeongdong 694-1. Agenda: To consider the audit report and sales reporting; to consider the 13th separate and consolidated financial statements referred to in subparagraph 1; to elect the directors of the gun (inside directors gimsuok); to consider the auditor of (thank you Lee, Myung - Hoon); to consider the remuneration limit of directors; to approve the remuneration limit of gratitude; to consider the date of board of directors' resolution (decision date) March 11, 2013; and to consider the other references concerning investment decisions.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
109820:KS 2,590.00 KRW -55.00

109820 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 109820.
View Industry Companies

Industry Analysis


Industry Average

Valuation 109820 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.2x
Price/Book 2.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENEMATRIX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at